237 related articles for article (PubMed ID: 10737887)
1. Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles.
Lu L; Stamatas GN; Mikos AG
J Biomed Mater Res; 2000 Jun; 50(3):440-51. PubMed ID: 10737887
[TBL] [Abstract][Full Text] [Related]
2. TGF-beta1 release from biodegradable polymer microparticles: its effects on marrow stromal osteoblast function.
Lu L; Yaszemski MJ; Mikos AG
J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S82-91. PubMed ID: 11314800
[TBL] [Abstract][Full Text] [Related]
3. Effects of transforming growth factor beta1 released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate) substrates.
Peter SJ; Lu L; Kim DJ; Stamatas GN; Miller MJ; Yaszemski MJ; Mikos AG
J Biomed Mater Res; 2000 Jun; 50(3):452-62. PubMed ID: 10737888
[TBL] [Abstract][Full Text] [Related]
4. Controlled release of NFkappaB decoy oligonucleotides from biodegradable polymer microparticles.
Zhu X; Lu L; Currier BL; Windebank AJ; Yaszemski MJ
Biomaterials; 2002 Jul; 23(13):2683-92. PubMed ID: 12059017
[TBL] [Abstract][Full Text] [Related]
5. The stability of insulin in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol.
Yeh MK
J Microencapsul; 2000; 17(6):743-56. PubMed ID: 11063421
[TBL] [Abstract][Full Text] [Related]
6. rhBMP-2 release from injectable poly(DL-lactic-co-glycolic acid)/calcium-phosphate cement composites.
Ruhe PQ; Hedberg EL; Padron NT; Spauwen PH; Jansen JA; Mikos AG
J Bone Joint Surg Am; 2003; 85-A Suppl 3():75-81. PubMed ID: 12925613
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta 1 release from oligo(poly(ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environment.
Holland TA; Tessmar JK; Tabata Y; Mikos AG
J Control Release; 2004 Jan; 94(1):101-14. PubMed ID: 14684275
[TBL] [Abstract][Full Text] [Related]
8. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.
Kim JH; Taluja A; Knutson K; Han Bae Y
J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769
[TBL] [Abstract][Full Text] [Related]
9. Controlled release of hyaluronan oligomers from biodegradable polymeric microparticle carriers.
Hedberg EL; Shih CK; Solchaga LA; Caplan AI; Mikos AG
J Control Release; 2004 Nov; 100(2):257-66. PubMed ID: 15544873
[TBL] [Abstract][Full Text] [Related]
10. The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol.
Lavelle EC; Yeh MK; Coombes AG; Davis SS
Vaccine; 1999 Feb; 17(6):512-29. PubMed ID: 10075157
[TBL] [Abstract][Full Text] [Related]
11. Modification of biodegradable poly(malate) and poly(lactic-co-glycolic acid) microparticles with low molecular polyethylene glycol.
Yoncheva K; Lambov N; Miloshev S
Drug Dev Ind Pharm; 2009 Apr; 35(4):449-54. PubMed ID: 19288298
[TBL] [Abstract][Full Text] [Related]
12. Controlled release from coated polymer microparticles embedded in tissue-engineered scaffolds.
Hu Y; Hollinger JO; Marra KG
J Drug Target; 2001; 9(6):431-8. PubMed ID: 11822815
[TBL] [Abstract][Full Text] [Related]
13. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
Kwon YM; Kim SW
Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317
[TBL] [Abstract][Full Text] [Related]
14. In vitro release of transforming growth factor-beta 1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels.
Holland TA; Tabata Y; Mikos AG
J Control Release; 2003 Sep; 91(3):299-313. PubMed ID: 12932709
[TBL] [Abstract][Full Text] [Related]
15. PLGA-PEG microspheres of teverelix: influence of polymer type on microsphere characteristics and on teverelix in vitro release.
Mallardé D; Boutignon F; Moine F; Barré E; David S; Touchet H; Ferruti P; Deghenghi R
Int J Pharm; 2003 Aug; 261(1-2):69-80. PubMed ID: 12878396
[TBL] [Abstract][Full Text] [Related]
16. Protein release microparticles based on the blend of poly(D,L-lactic-co-glycolic acid) and oligo-ethylene glycol grafted poly(L-lactide).
Cho KY; Choi SH; Kim CH; Nam YS; Park TG; Park JK
J Control Release; 2001 Oct; 76(3):275-84. PubMed ID: 11578742
[TBL] [Abstract][Full Text] [Related]
17. Controlled release of an osteogenic peptide from injectable biodegradable polymeric composites.
Hedberg EL; Tang A; Crowther RS; Carney DH; Mikos AG
J Control Release; 2002 Dec; 84(3):137-50. PubMed ID: 12468217
[TBL] [Abstract][Full Text] [Related]
18. In vitro degradation of porous poly(propylene fumarate)/poly(DL-lactic-co-glycolic acid) composite scaffolds.
Hedberg EL; Shih CK; Lemoine JJ; Timmer MD; Liebschner MA; Jansen JA; Mikos AG
Biomaterials; 2005 Jun; 26(16):3215-25. PubMed ID: 15603816
[TBL] [Abstract][Full Text] [Related]
19. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering.
Holland TA; Tabata Y; Mikos AG
J Control Release; 2005 Jan; 101(1-3):111-25. PubMed ID: 15588898
[TBL] [Abstract][Full Text] [Related]
20. Improved small molecule drug release from in situ forming poly(lactic-co-glycolic acid) scaffolds incorporating poly(β-amino ester) and hydroxyapatite microparticles.
Fisher PD; Palomino P; Milbrandt TA; Hilt JZ; Puleo DA
J Biomater Sci Polym Ed; 2014; 25(11):1174-93. PubMed ID: 24903524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
